Search alternatives:
"dramatic decreased" » "dramatic decrease" (Expand Search), "ratio decreased" (Expand Search)
"automatic decrease" » "dramatic decrease" (Expand Search)
"aromatic decrease" » "dramatic decrease" (Expand Search)
Showing 81 - 100 results of 219 for search '(("dramatic decreased") OR ((("aromatic decrease") OR ("automatic decrease"))))', query time: 0.29s Refine Results
  1. 81
    Changes in body length after exposure to organic solvents.

    Changes in body length after exposure to organic solvents. by Masahiro Tomioka (430683)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 82
    Correlation between acute behavioral toxicity with the organic solvent’s carbon number and lipid solubility.

    Correlation between acute behavioral toxicity with the organic solvent’s carbon number and lipid solubility. by Masahiro Tomioka (430683)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 83
    Organic solvent exposure causes defects in salt chemotaxis learning.

    Organic solvent exposure causes defects in salt chemotaxis learning. by Masahiro Tomioka (430683)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 84
    Base-case analysis results without or with PAP.

    Base-case analysis results without or with PAP. by Wei Li (7081)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  5. 85
    Correlation between the toxicity of organic solvents and their lipid solubility.

    Correlation between the toxicity of organic solvents and their lipid solubility. by Masahiro Tomioka (430683)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 86
    Results of scenario analyses for cCRT population.

    Results of scenario analyses for cCRT population. by Wei Li (7081)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  7. 87
    Locomotion speed after exposure to organic solvents in <i>tax-4</i> and <i>osm-9</i> mutants.

    Locomotion speed after exposure to organic solvents in <i>tax-4</i> and <i>osm-9</i> mutants. by Masahiro Tomioka (430683)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 88
    Changes in the amplitudes during locomotion after organic solvent exposure.

    Changes in the amplitudes during locomotion after organic solvent exposure. by Masahiro Tomioka (430683)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 89
    Correlation between the toxicity of ketones or cellosolves and their carbon number.

    Correlation between the toxicity of ketones or cellosolves and their carbon number. by Masahiro Tomioka (430683)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 90
    Alcohols and ketones affect posture during locomotion in opposite directions.

    Alcohols and ketones affect posture during locomotion in opposite directions. by Masahiro Tomioka (430683)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 91
    Cost-effectiveness acceptability curves of sugemalimab vs. placebo with and without PAP.

    Cost-effectiveness acceptability curves of sugemalimab vs. placebo with and without PAP. by Wei Li (7081)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  12. 92
    Validation of modeled PFS and OS data using updated GEMSTONE-301 and external data.

    Validation of modeled PFS and OS data using updated GEMSTONE-301 and external data. by Wei Li (7081)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  13. 93
    Model inputs: Base case values, ranges, and distributions for sensitivity analysis.

    Model inputs: Base case values, ranges, and distributions for sensitivity analysis. by Wei Li (7081)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  14. 94
    Effects of glucose exposure on motility and body length, and comparison among the effects of glucose and organic solvent exposure on motility.

    Effects of glucose exposure on motility and body length, and comparison among the effects of glucose and organic solvent exposure on motility. by Masahiro Tomioka (430683)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 95
    The proportion of subsequent immunotherapy and detailed treatment strategies varied with tumor histology type at progression for patients with stage III NSCLC.

    The proportion of subsequent immunotherapy and detailed treatment strategies varied with tumor histology type at progression for patients with stage III NSCLC. by Wei Li (7081)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  16. 96
    Tornado diagram of one-way deterministic sensitivity analysis (DSA) of sugemalimab vs. placebo. DSA for sCRT population with PAP.

    Tornado diagram of one-way deterministic sensitivity analysis (DSA) of sugemalimab vs. placebo. DSA for sCRT population with PAP. by Wei Li (7081)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  17. 97
    Raw statistics of the main figures.

    Raw statistics of the main figures. by Masahiro Tomioka (430683)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 98
    Results of scenario analyses for sCRT population.

    Results of scenario analyses for sCRT population. by Wei Li (7081)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  19. 99
    Salt chemotaxis learning assay.

    Salt chemotaxis learning assay. by Masahiro Tomioka (430683)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 100
    Raw statistics of the supporting figures.

    Raw statistics of the supporting figures. by Masahiro Tomioka (430683)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: